HUBUNGAN STATUS GIZI DENGAN KOMPLIKASI DIABETES MELITUS TIPE 2 DI RUMAH SAKIT ISLAM SITI RAHMAH
DOI:
https://doi.org/10.59003/nhj.v5i3.1633Keywords:
type 2 diabetes mellitus, nutritional status, BMI, complications, obesityAbstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with an increasing prevalence worldwide and is a major contributor to both microvascular and macrovascular complications. Nutritional status, particularly obesity, is considered to play a key role in the pathogenesis of these complications through mechanisms involving insulin resistance, chronic inflammation, and atherogenic dyslipidemia. However, locally based evidence on the association between nutritional status and T2DM complications remains limited. This research to evaluate the relationship between nutritional status, as measured by body mass index (BMI), and the types of T2DM complications among patients hospitalized at RSI Siti Rahmah Padang. This observational analytic study with a cross-sectional design included 65 T2DM patients with complications admitted between 2019 and 2021. Nutritional status was classified according to the WHO Western Pacific Region criteria, while complications were categorized into macroangiopathy, microangiopathy, and combined forms. Data were analyzed using the Kruskal–Wallis test with a significance level of p<0.05. Most patients were classified as having normal nutritional status (33.8%), followed by class I obesity (26.2%) and overweight (24.6%). Macroangiopathy was the most common complication (50.8%), followed by microangiopathy (46.2%) and combined complications (3.1%). Statistical analysis showed no significant association between nutritional status and the types of complications (p=0.052). BMI-based nutritional status was not significantly associated with the types of T2DM complications. Central adiposity indicators, such as waist circumference, may provide a more accurate measure of risk. Further studies with larger sample sizes are recommended.
Downloads
References
International Diabetes Federation. (2021). IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation.
Kementerian Kesehatan Republik Indonesia. (2023). Survei Kesehatan Indonesia 2023. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.
Kementerian Kesehatan Republik Indonesia. (2024). InfoDATIN Diabetes Mellitus. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan.
Perkumpulan Endokrinologi Indonesia. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia (Edisi 2021). Jakarta: PB PERKENI.
American Diabetes Association. (2023). Standards of Medical Care in Diabetes-2023. Diabetes Care, 46 (Suppl.1): S1-S291.
Dinas Kesehatan Provinsi Riau. (2023). Profil Kesehatan Provinsi Riau 2022. Pekanbaru: Dinas Kesehatan Provinsi Riau.
Pi-Sunyer X. (2009). The medical risks of obesity. Postgrad Med, 121 (6): 21-33.
Huxley R, Barzi F, Woodward M. (2006). Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ, 332 (7533): 73-78.
Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O. (2006). Obesity and risk for chronic renal failure. J Am Soc Nephrol, 17 (6): 1695-1702.
Kramer HJ, Saranathan A, Luke A, Durazo-Arvizu RA, Guichan C, Hou S. (2006). Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol, 17 (5): 1453-1459.
American Diabetes Association. (2024). Standards of Medical Care in Diabetes-2024. Diabetes Care, 47 (Suppl 1): S1-S180.
Garvey WT, Mechanick JI, Brett EM. (2022). American Association of Clinical Endocrinology Clinical Practice Guideline for Medical Care of Patients with Obesity. Endocr Pract, 28 (5): 1-100.
World Health Organization. (2011). Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: WHO.
Callaghan BC, Reynolds E, Banerjee M. (2020). Central obesity, weight change, and risk of peripheral neuropathy in type 2 diabetes. Diabetes Care, 43 (3): 511-518.
Larsson SC, Burgess S. (2021). Causal role of adiposity in cardiovascular disease: a Mendelian randomization study. Eur Heart J, 42 (34): 3381-3389.
Ryan DH, Kushner RF. (2024). The state of obesity 2024: epidemiology, pathophysiology, and management. N Engl J Med, 390 (5): 411-423.
Davies MJ, Aroda VR, Collins BS. (2024). Management of hyperglycemia in type 2 diabetes, 2024: consensus report. Diabetologia, 67 (5): 739-767.
Rothman KJ, Greenland S, Lash TL. (2021). Modern Epidemiology. 4th ed. Philadelphia: Wolters Kluwer.
Gregg EW, Cheng YJ, Saydah S. (2021). Trends in death rates among U.S. adults with and without diabetes between 1997 and 2018: findings from the National Health Interview Survey. Diabetes Care, 44 (12): 2770-2777.
Carnethon MR, De Chavez PJ, Biggs ML. (2012). Association of weight status with mortality in adults with incident diabetes. JAMA, 308 (6): 581-590.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pera Siska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
NHJ is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in this journal are Open Access articles published under the Creative Commons CC BY-NC-SA License This license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited.
Any derivative of the original must be distributed under the same license as the original.